Genetic Engineering of Resident Bacteria in the Gut Microbiome

Techniques by which to genetically manipulate members of the microbiota enable both the evaluation of host-microbe interactions and an avenue by which to monitor and modulate human physiology. Genetic engineering applications have traditionally focused on model gut residents, such as Escherichia coli and lactic acid bacteria. ABSTRACT Techniques by which to genetically manipulate members of the microbiota enable both the evaluation of host-microbe interactions and an avenue by which to monitor and modulate human physiology. Genetic engineering applications have traditionally focused on model gut residents, such as Escherichia coli and lactic acid bacteria. However, emerging efforts by which to develop synthetic biology toolsets for “nonmodel” resident gut microbes could provide an improved foundation for microbiome engineering. As genome engineering tools come online, so too have novel applications for engineered gut microbes. Engineered resident gut bacteria facilitate investigations of the roles of microbes and their metabolites on host health and allow for potential live microbial biotherapeutics. Due to the rapid pace of discovery in this burgeoning field, this minireview highlights advancements in the genetic engineering of all resident gut microbes.

[1]  H. Ploegh,et al.  Engineered Escherichia coli for the in situ secretion of therapeutic nanobodies in the gut. , 2023, Cell host & microbe.

[2]  B. Ye,et al.  Biomarker-responsive engineered probiotic diagnoses, records, and ameliorates inflammatory bowel disease in mice. , 2022, Cell host & microbe.

[3]  P. Hsu,et al.  Systematic discovery of recombinases for efficient integration of large DNA sequences into the human genome , 2022, Nature Biotechnology.

[4]  Thomas M Groseclose,et al.  Transcriptional programming in a Bacteroides consortium , 2022, Nature Communications.

[5]  J. Larsbrink,et al.  Investigation and Alteration of Organic Acid Synthesis Pathways in the Mammalian Gut Symbiont Bacteroides thetaiotaomicron , 2022, Microbiology spectrum.

[6]  N. Segata,et al.  Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer , 2022, Nature Medicine.

[7]  J. Wortman,et al.  SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection. , 2022, The New England journal of medicine.

[8]  D. Artis,et al.  Genetic manipulation of gut microbes enables single-gene interrogation in a complex microbiome , 2022, Cell.

[9]  Joshua J. Hamilton,et al.  Polysaccharide utilization loci in Bacteroides determine population fitness and community-level interactions. , 2022, Cell host & microbe.

[10]  J. Hasty,et al.  Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes , 2021, Cell.

[11]  Byung-Kwan Cho,et al.  Engineering Bacteroides thetaiotaomicron to produce non-native butyrate based on a genome-scale metabolic model-guided design. , 2021, Metabolic engineering.

[12]  W. S. Denney,et al.  Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study , 2021, Nature Metabolism.

[13]  Benjamin M. Scott,et al.  Self-tunable engineered yeast probiotics for the treatment of inflammatory bowel disease , 2021, Nature Medicine.

[14]  Erin H Wilson,et al.  A Computational Framework for Identifying Promoter Sequences in Nonmodel Organisms Using RNA-seq Data Sets. , 2021, ACS synthetic biology.

[15]  T. Lu,et al.  Synthetic Biology and Computer-Based Frameworks for Antimicrobial Peptide Discovery. , 2021, ACS nano.

[16]  A. Guss,et al.  Approaches to genetic tool development for rapid domestication of non-model microorganisms , 2021, Biotechnology for Biofuels.

[17]  Paul J. McMurdie,et al.  Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease , 2021, Gut microbes.

[18]  Daniel J. Blankenberg,et al.  Community-led, integrated, reproducible multi-omics with anvi’o , 2020, Nature Microbiology.

[19]  M. Fischbach,et al.  Bacterially Derived Tryptamine Increases Mucus Release by Activating a Host Receptor in a Mouse Model of Inflammatory Bowel Disease , 2020, iScience.

[20]  S. Mazmanian,et al.  The gut microbiota–brain axis in behaviour and brain disorders , 2020, Nature Reviews Microbiology.

[21]  Alexander C. Reis,et al.  An Automated Model Test System for Systematic Development and Improvement of Gene Expression Models. , 2020, ACS synthetic biology.

[22]  Dae-Hee Lee,et al.  A designed whole-cell biosensor for live diagnosis of gut inflammation through nitrate sensing. , 2020, Biosensors & bioelectronics.

[23]  Harris H. Wang,et al.  CRISPR RNA-guided integrases for high-efficiency and multiplexed bacterial genome engineering , 2020, bioRxiv.

[24]  E. Pamer,et al.  Functional and Genomic Variation between Human-Derived Isolates of Lachnospiraceae Reveals Inter- and Intra-Species Diversity. , 2020, Cell host & microbe.

[25]  Peter T. McKenney,et al.  Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells , 2020, Nature.

[26]  Christopher A. Voigt,et al.  Genetic circuit design automation for the gut resident species Bacteroides thetaiotaomicron , 2020, Nature Biotechnology.

[27]  Shane Thomas O’Donnell,et al.  The Progress of Multi-Omics Technologies: Determining Function in Lactic Acid Bacteria Using a Systems Level Approach , 2020, Frontiers in Microbiology.

[28]  Andrew C. Tolonen,et al.  A Targetron-Recombinase System for Large-Scale Genome Engineering of Clostridia , 2019, mSphere.

[29]  D. Figeys,et al.  Advancing functional and translational microbiome research using meta-omics approaches , 2019, Microbiome.

[30]  Bentley Lim,et al.  Genetic Manipulation of Wild Human Gut Bacteroides , 2019, Journal of bacteriology.

[31]  H. Flint,et al.  Heterologous gene expression in the human gut bacteria Eubacterium rectale and Roseburia inulinivorans by means of conjugative plasmids. , 2019, Anaerobe.

[32]  M. Fischbach,et al.  A metabolic pathway for bile acid dehydroxylation by the gut microbiome , 2019, bioRxiv.

[33]  A. Visel,et al.  CRAGE enables rapid activation of biosynthetic gene clusters in undomesticated bacteria , 2019, Nature Microbiology.

[34]  A. Arkin,et al.  GapMind: Automated Annotation of Amino Acid Biosynthesis , 2019, mSystems.

[35]  María-Eugenia Guazzaroni,et al.  Recent advances in plasmid-based tools for establishing novel microbial chassis. , 2019, Biotechnology advances.

[36]  L. Comstock,et al.  Streamlined Genetic Manipulation of Diverse Bacteroides and Parabacteroides Isolates from the Human Gut Microbiota , 2019, mBio.

[37]  K. Honda,et al.  Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus , 2019, Nature.

[38]  K. Winzer,et al.  A novel conjugal donor strain for improved DNA transfer into Clostridium spp. , 2019, Anaerobe.

[39]  N. Minton,et al.  RiboCas: A Universal CRISPR-Based Editing Tool for Clostridium. , 2019, ACS synthetic biology.

[40]  G. Borisy,et al.  Systematic evasion of the restriction-modification barrier in bacteria , 2019, Proceedings of the National Academy of Sciences.

[41]  Colin J. Brislawn,et al.  Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.

[42]  Katherine J Chou,et al.  Developing Riboswitch-Mediated Gene Regulatory Controls in Thermophilic Bacteria. , 2019, ACS synthetic biology.

[43]  Rafael Silva-Rocha,et al.  Expanding the toolbox of broad host-range transcriptional terminators for Proteobacteria through metagenomics , 2018, bioRxiv.

[44]  P. Bork,et al.  Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation , 2019, Nature Medicine.

[45]  Paul Theodor Pyl,et al.  Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer , 2019, Nature Medicine.

[46]  Lydia M. Contreras,et al.  Regulatory non-coding sRNAs in bacterial metabolic pathway engineering. , 2019, Metabolic engineering.

[47]  U. Müh,et al.  A Xylose-Inducible Expression System and a CRISPR Interference Plasmid for Targeted Knockdown of Gene Expression in Clostridioides difficile , 2019, Journal of bacteriology.

[48]  T. Guo,et al.  A rapid and versatile tool for genomic engineering in Lactococcus lactis , 2019, Microbial Cell Factories.

[49]  B. Ryffel,et al.  A New Bifidobacteria Expression SysTem (BEST) to Produce and Deliver Interleukin-10 in Bifidobacterium bifidum , 2018, Front. Microbiol..

[50]  Ying Zhang,et al.  Evolution of the Natural Transformation Protein, ComEC, in Bacteria , 2018, Front. Microbiol..

[51]  D. Antonopoulos,et al.  Healthy infants harbor intestinal bacteria that protect against food allergy , 2018, Nature Medicine.

[52]  Kamir J. Hiam,et al.  Depletion of microbiome-derived molecules in the host using Clostridium genetics , 2018, Science.

[53]  Adam B Fisher,et al.  Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria , 2018, Nature Biotechnology.

[54]  Amir I. Mina,et al.  A selective gut bacterial bile salt hydrolase alters host metabolism , 2018, eLife.

[55]  Jie Zhang,et al.  Multiplexed CRISPR-Cpf1-Mediated Genome Editing in Clostridium difficile toward the Understanding of Pathogenesis of C. difficile Infection. , 2018, ACS synthetic biology.

[56]  Weston R. Whitaker,et al.  Gut Microbiota-Produced Tryptamine Activates an Epithelial G-Protein-Coupled Receptor to Increase Colonic Secretion. , 2018, Cell host & microbe.

[57]  Timothy K Lu,et al.  An ingestible bacterial-electronic system to monitor gastrointestinal health , 2018, Science.

[58]  Weston R. Whitaker,et al.  An exclusive metabolic niche enables strain engraftment in the gut microbiota , 2018, Nature.

[59]  Eric J Alm,et al.  Metagenomic mining of regulatory elements enables programmable species-selective gene expression , 2018, Nature Methods.

[60]  Pamela A. Silver,et al.  Engineering bacteria for diagnostic and therapeutic applications , 2018, Nature Reviews Microbiology.

[61]  Vanni Bucci,et al.  Engineered Probiotic for the Inhibition of Salmonella via Tetrathionate-Induced Production of Microcin H47. , 2018, ACS infectious diseases.

[62]  Joseph A. Sorg,et al.  Using CRISPR-Cas9-mediated genome editing to generate C. difficile mutants defective in selenoproteins synthesis , 2017, Scientific Reports.

[63]  Howard M. Salis,et al.  An automated model test system for systematic development and improvement of gene expression models , 2017, bioRxiv.

[64]  Johannes Alneberg,et al.  DESMAN: a new tool for de novo extraction of strains from metagenomes , 2017, Genome Biology.

[65]  Finn Stirling,et al.  Rational Design of Evolutionarily Stable Microbial Kill Switches. , 2017, Molecular cell.

[66]  Nikhil U. Nair,et al.  Toward a genetic tool development pipeline for host-associated bacteria. , 2017, Current opinion in microbiology.

[67]  Jacob S. Lamson,et al.  Magic Pools: Parallel Assessment of Transposon Delivery Vectors in Bacteria , 2017, mSystems.

[68]  Michael Baym,et al.  Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation , 2017, Nature Biotechnology.

[69]  Weston R. Whitaker,et al.  Tunable Expression Tools Enable Single-Cell Strain Distinction in the Gut Microbiome , 2017, Cell.

[70]  Michael Zimmermann,et al.  Engineered Regulatory Systems Modulate Gene Expression of Human Commensals in the Gut , 2017, Cell.

[71]  William E Bentley,et al.  Engineered probiotic Escherichia coli can eliminate and prevent Pseudomonas aeruginosa gut infection in animal models , 2017, Nature Communications.

[72]  Jeffrey J. Tabor,et al.  Engineering bacterial thiosulfate and tetrathionate sensors for detecting gut inflammation , 2017, Molecular systems biology.

[73]  M. Fischbach,et al.  Modulation of a Circulating Uremic Solute via Rational Genetic Manipulation of the Gut Microbiota. , 2016, Cell host & microbe.

[74]  Tetsuya Hayashi,et al.  Counterselection employing mutated pheS for markerless genetic deletion in Bacteroides species. , 2016, Anaerobe.

[75]  W. D. de Vos,et al.  A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice , 2016, Nature Medicine.

[76]  Nigel P. Minton,et al.  A roadmap for gene system development in Clostridium , 2016, Anaerobe.

[77]  Christopher A. Voigt,et al.  Genetic circuit design automation , 2016, Science.

[78]  Paulo A. Garcia,et al.  Microfluidic Screening of Electric Fields for Electroporation , 2016, Scientific Reports.

[79]  Jason B. Williams,et al.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.

[80]  James J Collins,et al.  “Deadman” and “Passcode” microbial kill switches for bacterial containment , 2015, Nature chemical biology.

[81]  Irene M. Brockman,et al.  Dynamic metabolic engineering: New strategies for developing responsive cell factories , 2015, Biotechnology journal.

[82]  Timothy K Lu,et al.  Programming a Human Commensal Bacterium, Bacteroides thetaiotaomicron, to Sense and Respond to Stimuli in the Murine Gut Microbiota. , 2015, Cell systems.

[83]  Yong-hui Shi,et al.  Effects of different Lactobacillus reuteri on inflammatory and fat storage in high-fat diet-induced obesity mice model , 2015 .

[84]  Richard J. Roberts,et al.  REBASE—a database for DNA restriction and modification: enzymes, genes and genomes , 2009, Nucleic Acids Res..

[85]  Jan-Peter van Pijkeren,et al.  CRISPR–Cas9-assisted recombineering in Lactobacillus reuteri , 2014, Nucleic acids research.

[86]  A. Camilli,et al.  Multiplex genome editing by natural transformation , 2014, Proceedings of the National Academy of Sciences.

[87]  J. Collins,et al.  A brief history of synthetic biology , 2014, Nature Reviews Microbiology.

[88]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[89]  Andrew D Ellington,et al.  Generalized bacterial genome editing using mobile group II introns and Cre-lox , 2013, Molecular systems biology.

[90]  Klaus Ley,et al.  Bacterial colonization factors control specificity and stability of the gut microbiota , 2013, Nature.

[91]  Drew Endy,et al.  Precise and reliable gene expression via standard transcription and translation initiation elements , 2013, Nature Methods.

[92]  Feng Zhang,et al.  rNA-guided editing of bacterial genomes using crisPr-cas systems , 2016 .

[93]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[94]  Yun Zhang,et al.  A Mimicking-of-DNA-Methylation-Patterns Pipeline for Overcoming the Restriction Barrier of Bacteria , 2012, PLoS genetics.

[95]  A. Parker,et al.  Development of an IPTG inducible expression vector adapted for Bacteroides fragilis. , 2012, Plasmid.

[96]  Simon R. Carding,et al.  Treatment of colitis with a commensal gut bacterium engineered to secrete human tgf‐&bgr;1 under the control of dietary xylan , 2011, Inflammatory bowel diseases.

[97]  Jizhong Zhou,et al.  Ultrasound-Mediated DNA Transformation in Thermophilic Gram-Positive Anaerobes , 2010, PloS one.

[98]  Farren J. Isaacs,et al.  Tracking, tuning, and terminating microbial physiology using synthetic riboregulators , 2010, Proceedings of the National Academy of Sciences.

[99]  Christopher A. Voigt,et al.  Automated Design of Synthetic Ribosome Binding Sites to Precisely Control Protein Expression , 2009, Nature Biotechnology.

[100]  K. T. Holland,et al.  Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus , 2009, Gut.

[101]  J. Heap,et al.  A modular system for Clostridium shuttle plasmids. , 2009, Journal of microbiological methods.

[102]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[103]  Erik Remaut,et al.  A phase I trial with transgenic bacteria expressing interleukin-10 in Crohn's disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[104]  Laura S. Frost,et al.  Mobile genetic elements: the agents of open source evolution , 2005, Nature Reviews Microbiology.

[105]  P. Dilger,et al.  Engineering of the gut commensal bacterium Bacteroides ovatus to produce and secrete biologically active murine interleukin‐2 in response to xylan , 2005, Journal of applied microbiology.

[106]  J. Schölmerich,et al.  Preventive Effects of Escherichia coli Strain Nissle 1917 on Acute and Chronic Intestinal Inflammation in Two Different Murine Models of Colitis , 2004, Clinical Diagnostic Laboratory Immunology.

[107]  A. Lambowitz,et al.  Use of computer-designed group II introns to disrupt Escherichia coli DExH/D-box protein and DNA helicase genes. , 2004, Journal of molecular biology.

[108]  Jean Paul Remon,et al.  Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 , 2003, Nature Biotechnology.

[109]  Jun Wang,et al.  Production of Two Proteins Encoded by theBacteroides Mobilizable Transposon NBU1 Correlates with Time-Dependent Accumulation of the Excised NBU1 Circular Form , 2001, Journal of bacteriology.

[110]  G. Pérez-Martínez,et al.  Construction of compatible wide-host-range shuttle vectors for lactic acid bacteria and Escherichia coli. , 2001, Plasmid.

[111]  W. Fiers,et al.  Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. , 2000, Science.

[112]  J. Heap,et al.  The ClosTron: Mutagenesis in Clostridium refined and streamlined. , 2010, Journal of microbiological methods.

[113]  D. Hanahan,et al.  Plasmid transformation of Escherichia coli and other bacteria. , 1991, Methods in enzymology.